Golden State Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.11K Hold
61
﹤0.01% 1293
2026
Q1
$3.83K Sell
61
-123
-67% -$8.56K ﹤0.01% 1259
2025
Q4
$12.2K Buy
184
+96
+109% +$6.21K ﹤0.01% 1053
2025
Q3
$5.92K Sell
88
-37
-30% -$2.93K ﹤0.01% 1219
2025
Q2
$10.9K Hold
125
﹤0.01% 1058
2025
Q1
$8.54K Hold
125
﹤0.01% 1038
2024
Q4
$9.72K Buy
+125
New +$9.25K ﹤0.01% 972
2020
Q2
Sell
-1,240
Closed -$83K 421
2020
Q1
$83K Buy
+1,240
New +$77.2K 0.04% 279

Other funds holding DXCM

Golden State Wealth Management's DXCM Position: Q2 2026 in Review

Golden State Wealth Management held its DexCom (DXCM) position steady in Q2 2026 at 61 shares worth $4.11K. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

Golden State Wealth Management first reported a position in DXCM in Q1 2020 and has held it in 8 quarters since. The position peaked at $83K in Q1 2020. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Golden State Wealth Management held 61 shares of DexCom worth $4.11K as of Q2 2026.
  • Golden State Wealth Management left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1293 holding.
  • Golden State Wealth Management first reported a position in DexCom in Q1 2020 and has held it in 8 quarters since.
  • Golden State Wealth Management's DexCom position peaked at $83K in Q1 2020.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.